most likely this relates to the contract of $1.4 million last week, but maybe not. I'm trying to find out.
Sadly, the company is not even announcing new contracts. Picometrix a subsidiary of API got a 1.4 million dollar contract award with the Air Force yesterday. It's posted on my blog, and over on IV.
No chance of going bankrupt for over a year, imo.. Net working capital as of September 26, 2014 was $4.2 million. they are on the cusp of profitability but never seem to quite get there. I do anticipate increased HSOR and THz sales going forward incrementally. It looks bleak as hell now, but there is a good chance of better times ahead. Big risk, big reward.
terahertz technology. Advantest is moving into biological and pharmaceutical spectroscopy, and NDT, NDI
Yes they are involved at least to the extent they supplied the THz platform. Kaptin, Infrastrucs does not involve NASA, rather Microsoft and Carnegie Mellon.
this is a portion of RFID Journal post:
Willis and Wilson have created five prototype tag designs, each scanned with a different imaging configuration. The designs include unique tag locations within an object, differing tag geometries—how it is positioned and oriented inside the object—or the manufacture of a series of layers with shapes and patterns that can be identified via the THz scan. The two men also developed a variety of manufacturing methods by which the identifiers could be embedded in the object, including the use of additive fabrication with InfraStruct tags added to hollow internal areas of the item, or a subtractive method in which laser or vinyl cutters are used to remove raw material from the form in order to create a particular shape. The researchers employed several off-the-shelf THz emitter-receivers, including Picometrix's T-Ray 4000 model. The team has also developed the software that analyzes the transmissions reflected from a scan of each item, and then links the results to a specific object. -
you are correct plus there is the terahertz saf-t-chek, and Api Canada as wild cards which could also move this way up in a hurry
The greatest problem Verisante has is that it's not approved by the FDA, but this is not a critical problem, as they are shipping product in Canada and Europe, and aren't facing the cash burn issues of the magnitude of Mela. Too many people, have no real idea why they are here, or what is behind the technology. Always a mistake to invest in something you don't understand at all. Just my opinion, and good luck to all.
Verisante’s Aura series employs novel multispectral scanning shown to be accurate in the early detection of melanoma. But this device doesn’t only detect melanoma. Aura scans for 21 different cancer biomarkers in less than one second; providing immediate, accurate results. MelaFind, from what I understand only detects melanoma, without any detection capabilities for sqaumous and basal carcinomas.
MelaFind “results” are often, not the final diagnostic step but just the first step one in clinical assessment of suspicious lesions. Lesions found to be “non-evaluable” though a MelaFind exam often are required to be carefully re-evaluated and a biopsy, may be necessary.
Also, MelaFind has other limitations Aura does not have & can’t be used for non-pigmented , skin-colored lesions and only on lesions having a diameter between 2 mm and 22 mm, limiting its use.
Versante is backed by the BC Cancer Authority, and won the Popular Science award in 2012 for the most innovative medical device of the year. Doctors using the Raman-spectroscopy-based Aura can scan every mole on a patient’s body in 15 minutes, for far speedier and more accurate results. Just a matter of time. Sorry.
Weak demand is not being found elsewhere in the 100gig niche. ALU, is our largest customer, and I don't see any sign of slow-down, by them. Unfortuanely they are having to buy elsewhere until this latest problem gets resolved.
I don't think the anomaly detection device has received any "clearance" that I am aware of. I think it gets on the qualified providers list hopefully in March, but there are more hoops to jump through to get on the approved list for airport security.
Vrsef Installations of Beta Units have been completed at five leading dermatology clinics across Canada in Vancouver, Edmonton, Calgary, Oakville, Montreal and Markham. The Company continues to collect data from all sites for software verification purposes and has received valuable usability feedback.
In conjunction with the installations, the Company has completed technical training with Clarion Medical, the Company''s exclusive Canadian distributor. Clarion''s expert technicians will be responsible for the servicing of Aura™ in the field. Verisante also continues to work closely with Clarion and Bo-Pharma, the Company''s Benelux distributor, to train sales staff and provide sales and marketing materials in preparation for product launch.
Can't post link, anymore, but look at original post lots and lots of stuff going on in the world of terahertz, with API at the front....
Advanced Photonix (API): An Undervalued Play on a Growing Sector
Published Tuesday, April 17, 2012 by Justin Kuepper
Advanced Photonix Inc. (AMEX: API), a leading supplier of optoelectronic products around the world, similar to companies like Clearfield Inc. (NASDAQ: CLFD) and Neophotonics (NYSE: NPTN), and with customers like Huawei, Alcatel-Lucent, Oclaro and Finisar represents an undervalued play on the rapidly growing telecommunication space.
new post with picture of the anomaly detection device, and hand-held applications. See link on original post, which Yahoo won't let me post again.